Alloplant Implant: A Novel Biomaterial in the Management of Recalcitrant Glaucoma

Hon-Vu Q. Duong, MD; Kenneth C. Westfield, MD

Disclosures

July 30, 2008

Abstract

In North America, management of glaucoma includes observation, medical therapy, laser surgery, and ab-externa ocular surgery.[1] Although management of glaucoma in Russia does not differ greatly from that in the West, Russia has a unique biomaterial, Alloplant.

Various Alloplant biomaterials for ophthalmic surgery. Courtesy of the Alloplant Web site: https://www.alloplant.ru/index2_eng.php?page=3&pagel2=3

This unique biomaterial has been documented in Russian literature not only to lower intraocular pressure (IOP) but also to have the potential to induce normal tissue regeneration (allowing for restoration of normal eye physiology), decrease inflammatory response, prevent or minimize scarring, and stimulate regeneration of natural host tissues.


Reader Comments on: Alloplant Implant: A Novel Biomaterial in the Management of Recalcitrant Glaucoma
See reader comments on this article and provide your own.

Readers are encouraged to respond to the author at tenthsfg@msn.com or to George Lundberg, MD, Editor in Chief of The Medscape Journal of Medicine, for the editor's eyes only or for possible publication as an actual Letter in the Medscape Journal via email: glundberg@medscape.net

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....